![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Patient Immunotherapy Summit: Ovarian Cancer Brief (Cancer Research Institute) View |
![]() |
The Promise of Immunotherapy for Ovarian Cancer | Dana-Farber Cancer Institute (Dana-Farber Cancer Institute) View |
![]() |
Potential for Immunotherapy in Ovarian Cancer (OncLive) View |
![]() |
Introduction to Cancer Research Institute – NYC Immunotherapy Patient Summit 2017 (Cancer Research Institute) View |
![]() |
NY-ESO-1 immunotherapy for ovarian cancer (ecancer) View |
![]() |
2016 CRI Immunotherapy Patient Summit - Opening Remarks (Cancer Research Institute) View |
![]() |
2016 CRI Immunotherapy Patient Summit - Remarks (Cancer Research Institute) View |
![]() |
Selecting Optimal Upfront Therapy for Ovarian Cancer (Targeted Oncology) View |
![]() |
KEYNOTE-100 update: pembrolizumab in patients with advanced recurrent ovarian cancer (VJOncology) View |
![]() |
Tamron Hall’s Welcome at the 2020 CRI Virtual Immunotherapy Patient Summit (Cancer Research Institute) View |